Related resources
Search for item elsewhere
University researcher(s)
Academic department(s)
Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat.
Loddick S, Turnbull A, Rothwell NJ
J Cereb Blood Flow Metab. 1998;18( 2):176-9.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Use our list of Related resources to find this item elsewhere. Alternatively, request a copy from the Library's Document supply service.
Abstract
Interleukin-6 (IL-6) is a neurotrophic cytokine expressed in both neurons and glia. The present study shows that cerebral ischemia produced by permanent occlusion of the middle cerebral artery (MCAO) produces a dramatic increase in IL-6 bioactivity in the ischemic hemisphere within 2 hours of MCAO (167 +/- 55 IU versus sham: 50 +/- 35 IU), with further increases at 8 hours (3,456 +/- 1,162 IU) and 24 hours (6,088 +/- 1,772 IU). In a separate series of experiments, intracerebroventricular injection of recombinant IL-6 (3,100 or 31,000 IU) significantly reduced ischemic brain damage after MCAO (to 52% and 65% of controls, respectively). The large increase in endogenous IL-6 bioactivity in response to ischemia, together with the marked neuroprotection produced by exogenous IL-6 suggest that this cytokine is an important endogenous inhibitor of neuronal death during cerebral ischemia.
Keyword(s)
Animals; Body Temperature; Cell Death; Dose-Response Relationship, Drug; Injections, Intraventricular; Kinetics; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Support, Non-U.S. Gov't; administration & dosage: Interleukin-6; metabolism: Ischemic Attack, Transient; pharmacology: Recombinant Proteins; physiology: Neurons